Detalles de la búsqueda
1.
Effects of treatment with methimazole on circulating CD4+ and CD8+ T cells positive for programed cell death protein-1 and on subsets of CD4+ T cells in untreated hyperthyroid patients with Graves' disease.
Clin Endocrinol (Oxf)
; 97(6): 841-848, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-35692119
2.
Switching from the tablet to the powder formulation of levothyroxine corrects severe hypothyroidism in a patient with lactose intolerance.
Endocr J
; 69(8): 941-945, 2022 Aug 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35249899
3.
Increased Number of Mucosal-Associated Invariant T Cells Is Associated with the Inhibition of Nonalcoholic Fatty Liver Disease in High Fat Diet-Fed Mice.
Int J Mol Sci
; 23(23)2022 Dec 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36499635
4.
SFPQ associated with a co-activator for PPARγ, HELZ2, regulates key nuclear factors for adipocyte differentiation.
Biochem Biophys Res Commun
; 562: 139-145, 2021 07 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-34052659
5.
Symptomatic hypocalcemia after treatment for hyperthyroidism in a woman with chromosome 22q11.2 deletion syndrome complicated by Graves' disease: longitudinal changes in the number of subsets of CD4 and CD8 lymphocytes after thyroidectomy.
Endocr J
; 68(10): 1187-1195, 2021 Oct 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-33980771
6.
Acute effect of add-on therapy with tofogliflozin, a sodium glucose co-transporter 2 inhibitor, on 24-hours glucose profile and glycaemic variability evaluated by continuous glucose monitoring in patients with type 2 diabetes receiving dipeptidyl peptidase-4 inhibitors.
Int J Clin Pract
; 75(11): e14732, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34388297
7.
The SGLT2 Inhibitor Canagliflozin Prevents Carcinogenesis in a Mouse Model of Diabetes and Non-Alcoholic Steatohepatitis-Related Hepatocarcinogenesis: Association with SGLT2 Expression in Hepatocellular Carcinoma.
Int J Mol Sci
; 20(20)2019 Oct 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-31652578
8.
Usage of continuous glucose monitoring (CGM) for detecting an unrecognized hypoglycemia and management of glucocorticoid replacement therapy in adult patients with central hypoadrenalism.
Endocr J
; 65(5): 547-556, 2018 May 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-29618670
9.
Transducin ß-like 1, X-linked and nuclear receptor co-repressor cooperatively augment the ligand-independent stimulation of TRH and TSHß gene promoters by thyroid hormone receptors.
Endocr J
; 65(8): 805-813, 2018 Aug 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-29794369
10.
Propagation of adipogenic signals through an epigenomic transition state.
Genes Dev
; 24(10): 1035-44, 2010 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-20478996
11.
Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations.
Endocr J
; 64(1): 39-47, 2017 Jan 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-27681703
12.
Nivolumab-induced hypophysitis in a patient with advanced malignant melanoma.
Endocr J
; 63(10): 905-912, 2016 Oct 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-27440480
13.
Reversible Hypopituitarism Associated with Intravascular Large B-Cell Lymphoma: Case Report of Successful Immunochemotherapy.
Tohoku J Exp Med
; 238(3): 197-203, 2016 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-26936510
14.
Coordinated regulation of transcription and alternative splicing by the thyroid hormone receptor and its associating coregulators.
Biochem Biophys Res Commun
; 451(1): 24-9, 2014 Aug 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-25019984
15.
Somatic mutations of the catalytic subunit of cyclic AMP-dependent protein kinase (PRKACA) gene in Japanese patients with several adrenal adenomas secreting cortisol [Rapid Communication].
Endocr J
; 61(8): 825-32, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25069672
16.
A case of thyroid storm with a markedly elevated level of circulating soluble interleukin-2 receptor complicated by multiple organ failure and disseminated intravascular coagulation syndrome.
Endocr J
; 61(7): 691-6, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-24748455
17.
Empagliflozin increases plasma levels of citrulline, histidine, and α-aminobutyric acid in patients with type 2 diabetes: effects of a sodium-glucose co-transporter 2 inhibitor on the plasma amino acid profile.
Expert Opin Pharmacother
; 25(7): 937-944, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38809611
18.
Inhibition of IL-33 signaling ameliorate hepatic fibrosis with decreasing MCP-1 in a mouse model of diabetes and non-alcoholic steatohepatitis; comparison for luseogliflozin, an SGLT2 inhibitor.
J Diabetes Complications
; 38(1): 108650, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-38035640
19.
High serum levels of CCL11/Eotaxin-1 are associated with diabetic sensorimotor polyneuropathy and peripheral nerve function but not with cardiac autonomic neuropathy in people with type 2 diabetes.
Postgrad Med
; 136(3): 318-324, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38660919
20.
Relationship between reduced heart rate variability and increased arterial stiffness evaluated by the cardio-ankle vascular index in people with type 2 diabetes.
Diabetol Int
; 14(1): 94-102, 2023 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-36636156